| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 414,672 | 575,443 | 471,119 | 357,623 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit |
-
| 575,443 | 471,119 | 357,623 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 430,418 | 452,533 | 435,248 | 426,497 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | (69,440) | 71,797 | 1,179 | 1,144 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 53,694 | 51,113 | 34,692 | (70,018) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 53,694 | 51,113 | 34,692 | (70,018) | | Interest Expense | 12,000 | 11,594 | 11,390 | 11,601 | | Income Before Tax | 41,694 | 39,519 | 23,302 | (81,619) | | Income Tax Expense | (17,432) | 6,721 | 6,944 | (48,909) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 59,126 | 32,798 | 16,358 | (32,710) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 59,126 | 32,798 | 16,358 | (32,710) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $59,126 | $32,798 | $16,358 | ($32,710) |
|
0.01% Nasdaq 0.00%
Income Statement
